Judith Cohn
Profile
Dr. Cohn has more than 14 years experience in the pharmaceutical industry gained in progressively senior executive positions.
This has enabled her to gain a tremendous depth and breadth of knowledge in all aspects of international drug development, commercialization and life cycle management.
Prior to joining Procyon Biopharma, she was the Head of Clinical and Medical Affairs at Savient Pharmaceuticals Inc., a biotechnology company in East Brunswick, NJ and Chief Medical Officer and Vice President of Clinical Affairs for ReSearch Pharmaceutical Services.
Dr. Cohn has also occupied positions of increasing responsibility at Merck, Celltech-Medeva, Astra-Zeneca, and Abbott Laboratories.
Before entering industry Dr. Cohn was an Assistant Professor of Pulmonary and Critical Care Medicine at Rush Presbyterian St. Luke's in Chicago, IL.
She is a graduate of Northwestern University Medical School and holds a Ph.D.
in Microbiology/Immunology from the University of Pennsylvania and a Bachelor's Degree from the University of Wisconsin.
Former positions of Judith Cohn
Companies | Position | End |
---|---|---|
Procyon Biopharma, Inc.
Procyon Biopharma, Inc. Miscellaneous Commercial ServicesCommercial Services Procyon Biopharma, Inc. is a biopharmaceutical company engaged in the discovery and development of innovative cancer therapeutic, screening, and diagnostic products and technologies. Procyon has acquired four technologies of which two are broad platform technologies. These two are Prostate Secretory Protein (PSP94), for the prostate cancer market, and the ANA technology platform, that has been developed to improve the immune system and resistibility of cancer. The company is headquartered in Dorval in Québec, Canada | General Counsel | 03/03/2006 |
Training of Judith Cohn
Northwestern University | Undergraduate Degree |
University of Pennsylvania | Doctorate Degree |
University of Wisconsin | Undergraduate Degree |
Experiences
Positions held
Linked companies
Private companies | 1 |
---|---|
Procyon Biopharma, Inc.
Procyon Biopharma, Inc. Miscellaneous Commercial ServicesCommercial Services Procyon Biopharma, Inc. is a biopharmaceutical company engaged in the discovery and development of innovative cancer therapeutic, screening, and diagnostic products and technologies. Procyon has acquired four technologies of which two are broad platform technologies. These two are Prostate Secretory Protein (PSP94), for the prostate cancer market, and the ANA technology platform, that has been developed to improve the immune system and resistibility of cancer. The company is headquartered in Dorval in Québec, Canada | Commercial Services |
- Stock Market
- Insiders
- Judith Cohn